BioSpace News Archive

Drug Development

Cancer Prevention Pharmaceuticals (CPP) and Mallinckrodt Announce Results from Pivotal Phase 3 Trial of CPP-1X/Sulindac in Patients with Familial Adenomatous Polyposis

Full data to be presented in detail by CPP at Digestive Disease Week (DDW) conference on May 19, 2019 at 5:19 pm Pacific Time

May 7, 2019
·
4 min read
Deals

Mallinckrodt plc Reports Strong Growth in First Quarter 2019 Results, Raises Guidance for 2019, and Continues to Make Significant Advancements in Pipeline and Data Generation

Net sales up 4.7%, or 5.0% on a constant-currency basis, on $790.6 million, led by strong performance of hospital products and the Specialty Generics and Amitiza segment

May 7, 2019
·
14 min read
BioForest

QuoteWizard Study Finds the Fittest and Fattest States in America

QuoteWizard®, a LendingTree company, and one of the nation’s leading online insurance marketplaces, conducted a study that found the fittest and fattest states in America.

May 7, 2019
·
3 min read
Deals

Evofem Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update

Management to Host Conference Call at 11:00 a.m. EDT

May 7, 2019
·
8 min read
Business

ADURO Teams With Bon Secours Mercy Health To Accelerate The Connection Between Well-Being And Precision Care For Modernized Healthcare

ADURO’s Digital Platform Connects the Well-being and Clinical Care Experience for Employees, Patients and Community

May 7, 2019
·
4 min read
Policy

Exact Imaging’s Abdominal Imaging Release Receives CE Mark Approval

New EV5C Abdominal Transducer and Color Flow and Power Doppler capabilities enable the ExactVu™ micro-ultrasound system to provide a complete men’s health urological imaging solution

May 7, 2019
·
2 min read
Business

Sigilon Therapeutics Appoints Veteran Biotech Industry Leader John Cox to Board of Directors

Sigilon Therapeutics announced the appointment of distinguished biopharma executive John Cox, MBA, to its Board of Directors.

May 7, 2019
·
2 min read
Business

Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website

Haemonetics Corporation announced that financial results for its fourth quarter and fiscal year ended March 30, 2019 are available on its Investor relations website.

May 7, 2019
·
1 min read
Pharm Country

Eagle Pharmaceuticals Announces Positive Results of a Study Conducted in Partnership with the U.S. Military to Evaluate Neuroprotective Effects of RYANODEX for the Treatment of Nerve Agent Exposure

Statistically significant lower incidence of brain damage compared to control group, demonstrating neuroprotective properties of RYANODEX in treating nerve agent exposure

May 7, 2019
·
8 min read
Deals

Biohaven Pharmaceuticals Reports First Quarter 2019 Financial Results And Advancements In Neuroinnovation Platforms

Secured Priority Review Voucher (PRV) enabling expedited regulatory review of rimegepant Zydis® ODT New Drug Application (NDA)

May 7, 2019
·
18 min read